Short peptides break down Alzheimer’s tau fibrils
In a groundbreaking advance that could reshape therapeutic approaches for Alzheimer’s disease (AD), researchers have unveiled a detailed mechanism by which short D-enantiomeric peptides dismantle ultra-stable tau fibrils, offering fresh hope against one of the most elusive neurodegenerative disorders. The study illuminates how these small peptides—once considered unlikely champions against the formidable protein aggregates in […]
In a groundbreaking advance that could reshape therapeutic approaches for Alzheimer’s disease (AD), researchers have unveiled a detailed mechanism by which short D-enantiomeric peptides dismantle ultra-stable tau fibrils, offering fresh hope against one of the most elusive neurodegenerative disorders. The study illuminates how these small peptides—once considered unlikely champions against the formidable protein aggregates in […]
What's Your Reaction?
